EUVIMEDEUVIMED entdecken
Crossref

Low‐Dose Resveratrol Attenuates Toluene Diisocyanate‐Induced Steroid‐Resistant Asthma by Inhibiting HMGB1 Acetylation and Release

Yanhong Wang iD, Yanqing Le, Wenqu Zhao, Yisheng Lan, Xianru Peng, Jie Wu, Qian Zhang, Yinji Xu, Haijin Zhao

Journal of Biochemical and Molecular Toxicology · 2025-12 · 39 (12)

DOI: 10.1002/jbt.70631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 08.12.2025. Verfasst von Yanhong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medi…. Hauptthemen laut MEDLINE: Asthma, Toluene 2,4-Diisocyanate, Resveratrol, HMGB1 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: This study was funded by the National Natural Science Foundation of China (82070030, 82370029, 82200042, 82174313), Natural Science Foundation of Guangdong Pro….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resveratrol (RES) has been shown to be a promising protective agent against asthma. However, its role in the steroid‐resistant asthma is unknown. Studies showed RES displayed hormetic action, protecting the cells at a lower dose while inducing cytotoxicity at higher doses, which limits its clinical application. In this study, we determined the efficacy of different doses of RES in a steroid‐resistant asthma model. A toluene diisocyanate (TDI)‐induced steroid‐resistant murine asthma model was established. The effects of different doses of RES were tested both in vitro and in vivo. We observed low‐doses RES (1, 10 mg kg −1 ) ameliorated TDI‐induced airway hyperresponsiveness, airway neutrophil accumulation, mucus production and collogen deposition as well as the release of Th2 and Th17‐related cytokines. Yet, the high‐dose RES (100 mg kg −1 ) had no protective effects. As a SIRT1 activator, RES expectedly increased pulmonary SIRT1 expression at doses of 1,10 and 100 mg kg −1 , but only low‐dose RES (1, 10 mg kg −1 in mice and 10 μM in vitro) decreased TDI‐induced bronchial epithelial HMGB1 acetylation, nucleocytoplasmic translocation and release. Further, we found pulmonary p300, a nuclear histone deacetyltransferase, significantly upregulated by TDI was suppressed by only low‐doses RES (1, 10 mg·kg −1 ). In addition, low‐dose rather than high‐dose RES attenuated TDI‐induced bronchial epithelial DNA damage and mitochondrial oxidative stress. Our data suggested that low‐dose RES inhibits HMGB1 acetylation and release and maintains SIRT1‐p300 balance, which ameliorates airway inflammation in TDI‐induced steroid‐resistant asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaToluene 2,4-DiisocyanateResveratrolHMGB1 ProteinDrug ResistanceAnimalsMiceAcetylationSirtuin 1Mice, Inbred BALB CFemale

Stichwörter der Autor:innen

HMGB1ResveratrolSIRT1asthmatoluene diisocyanate

Substanzen

Toluene 2,4-DiisocyanateResveratrolHMGB1 ProteinSirtuin 1HMGB1 protein, mouseSirt1 protein, mouse

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, The Second Clinical College of Guangzhou University of C…
  • Department of Respiratory and Critical Care Medicine, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou, Yuexiu District, China.
  • Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Baiyun District, China.

ORCID-Profile: Yanhong Wang

Förderung

  • This study was funded by the National Natural Science Foundation of China (82070030, 82370029, 82200042, 82174313), Natural Science Foundation of Guangdong Pro…

Zitieren

APA

Wang, Y., Le, Y., Zhao, W., Lan, Y., Peng, X., Wu, J., Zhang, Q., Xu, Y., & Zhao, H. (2025). Low‐Dose Resveratrol Attenuates Toluene Diisocyanate‐Induced Steroid‐Resistant Asthma by Inhibiting HMGB1 Acetylation and Release. Journal of Biochemical and Molecular Toxicology, 39(12). https://doi.org/10.1002/jbt.70631

Vancouver

Wang Y, Le Y, Zhao W, Lan Y, Peng X, Wu J, et al. Low‐Dose Resveratrol Attenuates Toluene Diisocyanate‐Induced Steroid‐Resistant Asthma by Inhibiting HMGB1 Acetylation and Release. Journal of Biochemical and Molecular Toxicology. 2025;39(12). doi:10.1002/jbt.70631

BibTeX
@article{Wang2025,
  author = {Wang, Yanhong and Le, Yanqing and Zhao, Wenqu and Lan, Yisheng and Peng, Xianru and Wu, Jie and Zhang, Qian and Xu, Yinji and Zhao, Haijin},
  title = {Low‐Dose Resveratrol Attenuates Toluene Diisocyanate‐Induced Steroid‐Resistant Asthma by Inhibiting HMGB1 Acetylation and Release},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  volume = {39},
  number = {12},
  doi = {10.1002/jbt.70631}
}
Kostenlos starten →